161 related articles for article (PubMed ID: 23527718)
1. The role and clinical significance of YES-associated protein 1 in human osteosarcoma.
Zhang YH; Li B; Shen L; Shen Y; Chen XD
Int J Immunopathol Pharmacol; 2013; 26(1):157-67. PubMed ID: 23527718
[TBL] [Abstract][Full Text] [Related]
2. Knockdown of YAP1 inhibits the proliferation of osteosarcoma cells in vitro and in vivo.
Yang Z; Zhang M; Xu K; Liu L; Hou WK; Cai YZ; Xu P; Yao JF
Oncol Rep; 2014 Sep; 32(3):1265-72. PubMed ID: 24993351
[TBL] [Abstract][Full Text] [Related]
3. Long noncoding RNA APTR contributes to osteosarcoma progression through repression of miR-132-3p and upregulation of yes-associated protein 1.
Guan H; Shang G; Cui Y; Liu J; Sun X; Cao W; Wang Y; Li Y
J Cell Physiol; 2019 Jun; 234(6):8998-9007. PubMed ID: 30317613
[TBL] [Abstract][Full Text] [Related]
4. miR-1285-3p is a potential prognostic marker in human osteosarcoma and functions as a tumor suppressor by targeting YAP1.
Hu XH; Dai J; Shang HL; Zhao ZX; Hao YD
Cancer Biomark; 2019; 25(1):1-10. PubMed ID: 31006663
[TBL] [Abstract][Full Text] [Related]
5. Knockdown of galectin-1 suppresses the growth and invasion of osteosarcoma cells through inhibition of the MAPK/ERK pathway.
Miao JH; Wang SQ; Zhang MH; Yu FB; Zhang L; Yu ZX; Kuang Y
Oncol Rep; 2014 Oct; 32(4):1497-504. PubMed ID: 25069486
[TBL] [Abstract][Full Text] [Related]
6. YES-associated protein 1 promotes adenocarcinoma growth and metastasis through activation of the receptor tyrosine kinase Axl.
Cui ZL; Han FF; Peng XH; Chen X; Luan CY; Han RC; Xu WG; Guo XJ
Int J Immunopathol Pharmacol; 2012; 25(4):989-1001. PubMed ID: 23298489
[TBL] [Abstract][Full Text] [Related]
7. Knockdown of AXL receptor tyrosine kinase in osteosarcoma cells leads to decreased proliferation and increased apoptosis.
Zhang Y; Tang YJ; Man Y; Pan F; Li ZH; Jia LS
Int J Immunopathol Pharmacol; 2013; 26(1):179-88. PubMed ID: 23527720
[TBL] [Abstract][Full Text] [Related]
8. Knockdown of TNFAIP1 inhibits growth and induces apoptosis in osteosarcoma cells through inhibition of the nuclear factor-κB pathway.
Zhang CL; Wang C; Yan WJ; Gao R; Li YH; Zhou XH
Oncol Rep; 2014 Sep; 32(3):1149-55. PubMed ID: 24969828
[TBL] [Abstract][Full Text] [Related]
9. Long non-coding RNA XIST promotes osteosarcoma progression by targeting YAP via miR-195-5p.
Yang C; Wu K; Wang S; Wei G
J Cell Biochem; 2018 Jul; 119(7):5646-5656. PubMed ID: 29384226
[TBL] [Abstract][Full Text] [Related]
10. HMGB1 promotes cellular proliferation and invasion, suppresses cellular apoptosis in osteosarcoma.
Meng Q; Zhao J; Liu H; Zhou G; Zhang W; Xu X; Zheng M
Tumour Biol; 2014 Dec; 35(12):12265-74. PubMed ID: 25168370
[TBL] [Abstract][Full Text] [Related]
11. Hedgehog signaling induces osteosarcoma development through Yap1 and H19 overexpression.
Chan LH; Wang W; Yeung W; Deng Y; Yuan P; Mak KK
Oncogene; 2014 Oct; 33(40):4857-66. PubMed ID: 24141783
[TBL] [Abstract][Full Text] [Related]
12. microRNA‑625 targets Yes‑associated protein 1 to suppress cell proliferation and invasion of osteosarcoma.
Luo Z; Wu G; Zhang D; Liu J; Ran R
Mol Med Rep; 2018 Jan; 17(1):2005-2011. PubMed ID: 29257207
[TBL] [Abstract][Full Text] [Related]
13. S1P/S1PR3 axis promotes aerobic glycolysis by YAP/c-MYC/PGAM1 axis in osteosarcoma.
Shen Y; Zhao S; Wang S; Pan X; Zhang Y; Xu J; Jiang Y; Li H; Zhang Q; Gao J; Yang Q; Zhou Y; Jiang S; Yang H; Zhang Z; Zhang R; Li J; Zhou D
EBioMedicine; 2019 Feb; 40():210-223. PubMed ID: 30587459
[TBL] [Abstract][Full Text] [Related]
14. Knockdown of CXCR7 inhibits proliferation and invasion of osteosarcoma cells through inhibition of the PI3K/Akt and β-arrestin pathways.
Zhang Y; Yang CQ; Gao Y; Wang C; Zhang CL; Zhou XH
Oncol Rep; 2014 Sep; 32(3):965-72. PubMed ID: 24969680
[TBL] [Abstract][Full Text] [Related]
15. MALAT1 promotes the proliferation and metastasis of osteosarcoma cells by activating the PI3K/Akt pathway.
Dong Y; Liang G; Yuan B; Yang C; Gao R; Zhou X
Tumour Biol; 2015 Mar; 36(3):1477-86. PubMed ID: 25431257
[TBL] [Abstract][Full Text] [Related]
16. Knockdown of S100A4 decreases tumorigenesis and metastasis in osteosarcoma cells by repression of matrix metalloproteinase-9.
Zhang G; Li M; Jin J; Bai Y; Yang C
Asian Pac J Cancer Prev; 2011; 12(8):2075-80. PubMed ID: 22292654
[TBL] [Abstract][Full Text] [Related]
17. RASSF5 inhibits growth and invasion and induces apoptosis in osteosarcoma cells through activation of MST1/LATS1 signaling.
Zhou XH; Yang CQ; Zhang CL; Gao Y; Yuan HB; Wang C
Oncol Rep; 2014 Oct; 32(4):1505-12. PubMed ID: 25109282
[TBL] [Abstract][Full Text] [Related]
18. Knockdown of HuR represses osteosarcoma cells migration, invasion and stemness through inhibition of YAP activation and increases susceptibility to chemotherapeutic agents.
Xu W; Chen C; Xu R; Li Y; Hu R; Li Z; Zhu X
Biomed Pharmacother; 2018 Jun; 102():587-593. PubMed ID: 29597092
[TBL] [Abstract][Full Text] [Related]
19. The transcription factor RUNX2 fuels YAP1 signaling and gastric cancer tumorigenesis.
Guo Z; Zhou K; Wang Q; Huang Y; Ji J; Peng Y; Zhang X; Zheng T; Zhang Z; Chong D; Yang Z
Cancer Sci; 2021 Sep; 112(9):3533-3544. PubMed ID: 34160112
[TBL] [Abstract][Full Text] [Related]
20. Long noncoding RNA kcna3 inhibits the progression of colorectal carcinoma through down-regulating YAP1 expression.
Zhong X; Lü M; Wan J; Zhou T; Qin B
Biomed Pharmacother; 2018 Nov; 107():382-389. PubMed ID: 30099342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
